Showing results (441-450 of 461) with videos related to
Sort By:
Pageof 47
Blood|January 10, 2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma studySally F Barrington, Amy A Kirkwood, Antonella Franceschetto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 6, 2024
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal AdenocarcinomaAndrew L Coveler, Matthew J Reilley, Mark Zalupski, et al.Scientific Reports|March 13, 2024
A biogeographical appraisal of the threatened South East Africa Montane Archipelago ecoregionJulian Bayliss, Gabriela B Bittencourt-Silva, William R Branch, et al.Angewandte Chemie (International Ed. in English)|October 6, 2018
Discovery of an MLLT1/3 YEATS Domain Chemical ProbeMoses Moustakim, Thomas Christott, Octovia P Monteiro, et al.JTO Clinical and Research Reports|April 27, 2026
Durvalumab Plus Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARDByoung Chul Cho, Makoto Nishio, Myung-Ju Ahn, et al.Journal of Medicinal Chemistry|March 8, 2021
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation StrategyJ Willem M Nissink, Sana Bazzaz, Carolyn Blackett, et al.BMJ Open|June 25, 2017
A combined randomised and observational study of surgery for fractures in the distal radius in the elderly (CROSSFIRE)-a study protocolIan A Harris, Justine M Naylor, Andrew Lawson, et al.The Science of the Total Environment|October 11, 2020
Behavioural responses of breeding arctic sandpipers to ground-surface temperature and primary productivityNicolas Meyer, Loïc Bollache, Matthias Galipaud, et al.Trials|July 17, 2020
A Combined Randomised and Observational Study of Surgery for Fractures In the distal Radius in the Elderly (CROSSFIRE): a statistical analyses planAndrew Lawson, Justine Naylor, Rachelle Buchbinder, et al.The Lancet. Haematology|March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trialDavid I Marks, Amy A Kirkwood, Clare J Rowntree, et al.Pageof 47